145 related articles for article (PubMed ID: 20580477)
1. Change in use of gadolinium-enhanced magnetic resonance studies in kidney disease patients after US Food and Drug Administration warnings: a cross-sectional study of Veterans Affairs Health Care System data from 2005-2008.
Kim KH; Fonda JR; Lawler EV; Gagnon D; Kaufman JS
Am J Kidney Dis; 2010 Sep; 56(3):458-67. PubMed ID: 20580477
[TBL] [Abstract][Full Text] [Related]
2. Detection and awareness of moderate to advanced CKD by primary care practitioners: a cross-sectional study from Italy.
Minutolo R; De Nicola L; Mazzaglia G; Postorino M; Cricelli C; Mantovani LG; Conte G; Cianciaruso B
Am J Kidney Dis; 2008 Sep; 52(3):444-53. PubMed ID: 18468747
[TBL] [Abstract][Full Text] [Related]
3. Nephrogenic systemic fibrosis and gadolinium-enhanced magnetic resonance imaging: does a US Food and Drug Administration alert influence practice patterns in CKD?
Martin DR
Am J Kidney Dis; 2010 Sep; 56(3):427-30. PubMed ID: 20728788
[No Abstract] [Full Text] [Related]
4. Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelines.
Wang Y; Alkasab TK; Narin O; Nazarian RM; Kaewlai R; Kay J; Abujudeh HH
Radiology; 2011 Jul; 260(1):105-11. PubMed ID: 21586680
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of decreased glomerular filtration rate in patients seeking non-nephrological medical care--an evaluation using IDMS-traceable creatinine based MDRD as well as Mayo Clinic quadratic equation estimates.
Risch L; Saely CH; Neyer U; Hoefle G; Gouya G; Zerlauth M; Risch GM; Risch M; Drexel H
Clin Chim Acta; 2007 Mar; 378(1-2):71-7. PubMed ID: 17157286
[TBL] [Abstract][Full Text] [Related]
6. [Nephrogenic systemic fibrosis].
Breitschaft A; Stahlmann R
Med Monatsschr Pharm; 2009 Oct; 32(10):377-82. PubMed ID: 19886227
[TBL] [Abstract][Full Text] [Related]
7. Mortality risk stratification in chronic kidney disease: one size for all ages?
O'Hare AM; Bertenthal D; Covinsky KE; Landefeld CS; Sen S; Mehta K; Steinman MA; Borzecki A; Walter LC
J Am Soc Nephrol; 2006 Mar; 17(3):846-53. PubMed ID: 16452492
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey.
Coresh J; Astor BC; Greene T; Eknoyan G; Levey AS
Am J Kidney Dis; 2003 Jan; 41(1):1-12. PubMed ID: 12500213
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study.
White SL; Polkinghorne KR; Atkins RC; Chadban SJ
Am J Kidney Dis; 2010 Apr; 55(4):660-70. PubMed ID: 20138414
[TBL] [Abstract][Full Text] [Related]
10. Performance of the Cockcroft-Gault and modification of diet in renal disease equations in estimating GFR in ill hospitalized patients.
Poggio ED; Nef PC; Wang X; Greene T; Van Lente F; Dennis VW; Hall PM
Am J Kidney Dis; 2005 Aug; 46(2):242-52. PubMed ID: 16112042
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of various glomerular filtration rates estimating equations in patients with chronic kidney disease and diabetes.
Li HX; Xu GB; Wang XJ; Zhang XC; Yang JM
Chin Med J (Engl); 2010 Mar; 123(6):745-51. PubMed ID: 20368098
[TBL] [Abstract][Full Text] [Related]
12. Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease.
Tsui JI; Vittinghoff E; Shlipak MG; Bertenthal D; Inadomi J; Rodriguez RA; O'Hare AM
Arch Intern Med; 2007 Jun; 167(12):1271-6. PubMed ID: 17592100
[TBL] [Abstract][Full Text] [Related]
13. The safety of gadolinium in patients with stage 3 and 4 renal failure.
Ergün I; Keven K; Uruç I; Ekmekçi Y; Canbakan B; Erden I; Karatan O
Nephrol Dial Transplant; 2006 Mar; 21(3):697-700. PubMed ID: 16326736
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for dosing antimicrobials.
Hermsen ED; Maiefski M; Florescu MC; Qiu F; Rupp ME
Pharmacotherapy; 2009 Jun; 29(6):649-55. PubMed ID: 19476418
[TBL] [Abstract][Full Text] [Related]
15. The epidemiology of adult chronic kidney disease in a population-based study in Iran: prevalence and associated risk factors.
Safarinejad MR
J Nephrol; 2009; 22(1):99-108. PubMed ID: 19229824
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of chronic kidney disease based on estimated glomerular filtration rate and proteinuria in Icelandic adults.
Viktorsdottir O; Palsson R; Andresdottir MB; Aspelund T; Gudnason V; Indridason OS
Nephrol Dial Transplant; 2005 Sep; 20(9):1799-807. PubMed ID: 15928100
[TBL] [Abstract][Full Text] [Related]
17. Patient selection has a strong impact on cystatin C and Modification of Diet in Renal Disease (MDRD) estimated glomerular filtration rate.
Larsson A; Flodin M; Hansson LO; Carlsson L
Clin Biochem; 2008 Nov; 41(16-17):1355-61. PubMed ID: 18674527
[TBL] [Abstract][Full Text] [Related]
18. Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database.
Stevens LA; Manzi J; Levey AS; Chen J; Deysher AE; Greene T; Poggio ED; Schmid CH; Steffes MW; Zhang YL; Van Lente F; Coresh J
Am J Kidney Dis; 2007 Jul; 50(1):21-35. PubMed ID: 17591522
[TBL] [Abstract][Full Text] [Related]
19. The practical implications of using standardized estimation equations in calculating the prevalence of chronic kidney disease.
Quinn MP; Rainey A; Cairns KJ; Marshall AH; Savage G; Kee F; Peter Maxwell A; Reaney E; Fogarty DG
Nephrol Dial Transplant; 2008 Feb; 23(2):542-8. PubMed ID: 17890743
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of anemia in patients with chronic kidney disease.
McClellan W; Aronoff SL; Bolton WK; Hood S; Lorber DL; Tang KL; Tse TF; Wasserman B; Leiserowitz M
Curr Med Res Opin; 2004 Sep; 20(9):1501-10. PubMed ID: 15383200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
